EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy

Rita Mastrogiacomo iD, Daniela Valeria Miniero, Mariagrazia Rullo iD, Federica Rizzi iD, Gianluca Minervini, Annamaria Panniello, Marinella Striccoli iD, Elisabetta Fanizza iD, Roberto Comparelli, Maria Lucia Curri iD, Marco Catto iD, Grazia Maria Liuzzi und 3 weitere

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 2918-2934

DOI: 10.1021/acs.molpharmaceut.5c01754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.04.2026. Verfasst von Rita Mastrogiacomo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Bari Aldo Moro, Via E. Orabona 4, Bari 70126, Italy. Hauptthemen laut MEDLINE: Antioxidants, Monoamine Oxidase Inhibitors, Neurodegenerative Diseases, Drug Carriers. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Universita degli Studi di Bari Aldo Moro, European Social Fund Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsMonoamine Oxidase InhibitorsNeurodegenerative DiseasesDrug CarriersNanostructuresLipidsBrainHumansBlood-Brain BarrierMonoamine OxidaseCarbon Quantum DotsCell Line, TumorNeuroprotective AgentsAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

MAO B inhibitorantioxidant activityblood–brain barriernanostructured lipid carriersneurodegenerative diseases

Substanzen

AntioxidantsMonoamine Oxidase InhibitorsDrug CarriersLipidsMonoamine OxidaseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Chemistry, University of Bari Aldo Moro, Via E. Orabona 4, Bari 70126, Italy.
  • Institute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.
  • Bari Research Unit, National Interuniversity Consortium of Materials Science and Technology (INSTM), 70126 Bari, Italy.
  • Department Medicine and Surgery, LUM University Giuseppe Degennaro, Casamassima 70010, Italy.
  • Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari 70125, Italy.
  • Department of Biosciences, Biotechnologies and Environment, University of Bari "Aldo Moro", Bari 70126, Italy.

ORCID-Profile: Rita Mastrogiacomo, Mariagrazia Rullo, Federica Rizzi, Marinella Striccoli, Elisabetta Fanizza, Maria Lucia Curri, Marco Catto, Leonardo Pisani, Tiziana Latronico, Nicoletta Depalo

Förderung

  • European Regional Development Fund
  • Universita degli Studi di Bari Aldo Moro
  • European Social Fund Plus

Zitieren

APA

Mastrogiacomo, R., Miniero, D. V., Rullo, M., Rizzi, F., Minervini, G., Panniello, A., Striccoli, M., Fanizza, E., Comparelli, R., Curri, M. L., Catto, M., Liuzzi, G. M., Pisani, L., Latronico, T., & Depalo, N. (2026). Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular Pharmaceutics, 23(5), 2918-2934. https://doi.org/10.1021/acs.molpharmaceut.5c01754

Vancouver

Mastrogiacomo R, Miniero DV, Rullo M, Rizzi F, Minervini G, Panniello A, et al. Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular Pharmaceutics. 2026;23(5):2918-2934. doi:10.1021/acs.molpharmaceut.5c01754

BibTeX
@article{Mastrogiacomo2026,
  author = {Mastrogiacomo, Rita and Miniero, Daniela Valeria and Rullo, Mariagrazia and Rizzi, Federica and Minervini, Gianluca and Panniello, Annamaria and Striccoli, Marinella and Fanizza, Elisabetta and Comparelli, Roberto and Curri, Maria Lucia and Catto, Marco and Liuzzi, Grazia Maria and Pisani, Leonardo and Latronico, Tiziana and Depalo, Nicoletta},
  title = {Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {2918--2934},
  doi = {10.1021/acs.molpharmaceut.5c01754}
}
Kostenlos starten →